PubRank

A M Sugar

Author PubWeight™ 76.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 1994 9.11
2 Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1992 5.84
3 A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med 1992 3.65
4 NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med 1994 2.60
5 Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Am J Med 1989 2.20
6 Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000 2.15
7 Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995 2.11
8 Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene. Infect Immun 1998 1.76
9 Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993 1.46
10 Paracoccidioidomycosis and AIDS: an overview. Clin Infect Dis 1995 1.43
11 Comparative activities of UK-49,858 and amphotericin B against Blastomyces dermatitidis infections in mice. Antimicrob Agents Chemother 1986 1.42
12 Clinical research. Science 2000 1.39
13 Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis 1990 1.32
14 Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. Am J Med 1983 1.26
15 Rapid diagnosis of nocardiosis with an enzyme immunoassay. J Infect Dis 1987 1.20
16 Antibody response in human nocardiosis: identification of two immunodominant culture-filtrate antigens derived from Nocardia asteroides. J Infect Dis 1985 1.19
17 Identification of a common immunodominant protein in culture filtrates of three Nocardia species and use in etiologic diagnosis of mycetoma. J Clin Microbiol 1987 1.12
18 Cloning and nucleotide sequence of a specific DNA fragment from Paracoccidioides brasiliensis. J Clin Microbiol 1995 1.11
19 Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J Acquir Immune Defic Syndr Hum Retrovirol 1995 1.10
20 Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug. J Antimicrob Chemother 1994 1.08
21 Paracoccidioidomycosis in the immunosuppressed host: report of a case and review of the literature. Am Rev Respir Dis 1984 1.08
22 Capnocytophaga septicemia. N Engl J Med 1980 1.07
23 Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature. Cancer 1985 1.04
24 What's the price of a research subject? N Engl J Med 1999 0.99
25 Immunological activation of polymorphonuclear neutrophils for fungal killing: studies with murine cells and blastomyces dermatitidis in vitro. J Leukoc Biol 1984 0.98
26 Rapid assay for determination of trimethoprim and sulfamethoxazole levels in serum by spectrofluorometry. Antimicrob Agents Chemother 1979 0.96
27 Susceptibility of Blastomyces dermatitidis strains to products of oxidative metabolism. Infect Immun 1983 0.95
28 Bacillus licheniformis sepsis. JAMA 1977 0.95
29 Murine pulmonary macrophages: evaluation of lung lavage fluids, miniaturized monolayers, and candidacidal activity. Am Rev Respir Dis 1983 0.95
30 Enhanced oxidative burst in immunologically activated but not elicited polymorphonuclear leukocytes correlates with fungicidal activity. Infect Immun 1985 0.94
31 Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole. J Med Vet Mycol 1996 0.94
32 Effect of cilofungin (LY121019), a fungal cell wall synthesis inhibitor, on interactions of Candida albicans with human neutrophils. J Antimicrob Chemother 1989 0.92
33 New rapid assay for nafcillin in serum by spectrofluorometry. Antimicrob Agents Chemother 1979 0.90
34 Ketoconazole treatment of coccidioidal meningitis. Ann N Y Acad Sci 1988 0.89
35 Short report: use of the polymerase chain reaction to detect Paracoccidioides brasiliensis in murine paracoccidioidomycosis. Am J Trop Med Hyg 1998 0.89
36 Activation of peritoneal macrophages by concanavalin A or Mycobacterium bovis BCG for fungicidal activity against Blastomyces dermatitidis and effect of specific antibody and complement. Infect Immun 1983 0.88
37 Fungal meningitis. Infect Dis Clin North Am 1990 0.87
38 Herpes zoster ophthalmicus and granulomatous angiitis. An ill-appreciated cause of stroke. J Am Geriatr Soc 1986 0.86
39 The iron-hydrogen peroxide-iodide system is fungicidal: activity against the yeast phase of Blastomyces dermatitidis. J Leukoc Biol 1984 0.86
40 Nocardia in naturally acquired and experimental infections in animals. J Hyg (Lond) 1983 0.86
41 Fluconazole in transplant recipients: options and limitations. Transpl Infect Dis 2000 0.85
42 Candida esophagitis. Adv Intern Med 1991 0.85
43 Synthesis of heat-shock proteins in mycelia and yeast forms of Paracoccidioides brasiliensis. J Med Microbiol 1994 0.85
44 In vitro activity of LY121019 against Candida species and Torulopsis glabrata. Eur J Clin Microbiol Infect Dis 1988 0.85
45 Fungicidal activity of murine broncho-alveolar macrophages against Blastomyces dermatitidis. J Med Microbiol 1986 0.84
46 Making antifungal susceptibility testing a clinically useful tool. Clin Infect Dis 1997 0.82
47 Possible thiabendazole-induced theophylline toxicity. Am Rev Respir Dis 1980 0.81
48 Combined treatment: antifungal drugs with antibodies, cytokines or drugs. Med Mycol 2000 0.80
49 Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole. Clin Infect Dis 1996 0.80
50 Characteristics of the pulmonary cellular immune response to two strains of Blastomyces dermatitidis in the mouse. Am Rev Respir Dis 1985 0.79
51 Interaction of fluconazole and cyclosporine. Ann Intern Med 1989 0.79
52 Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia. Arch Intern Med 1985 0.79
53 A cephalosporin active in vivo against Nocardia: efficacy of cefotaxime in murine model of acute pulmonary nocardiosis. J Hyg (Lond) 1983 0.78
54 Pneumocystis carinii pneumonia associated with solid ectopic corticotropin-producing tumors. Arch Neurol 1992 0.78
55 Effect of various common beverages on the dissolution of ketoconazole tablets. AIDS 1992 0.77
56 Gonococcal endocarditis in a patient with mitral valve prolapse: study of host immunology and organism characteristics. Am J Med Sci 1982 0.77
57 Toxic effect of products of oxidative metabolism on the yeast form of Paracoccidioides brasiliensis. J Med Microbiol 1984 0.77
58 Pneumocystis carinii pneumonia complicating somatostatin therapy of Cushing's syndrome in a patient with metastatic pancreatic islet cell carcinoma and Zollinger-Ellison syndrome. Am J Gastroenterol 1991 0.75
59 P&T Committee review of fluconazole: an effective alternative to antifungal therapy. Hosp Formul 1990 0.75
60 Case 49-1988: Histoplasma capsulatum or Blastomyces dermatitidis? N Engl J Med 1989 0.75
61 Ketoconazole effects. Ann Intern Med 1982 0.75
62 Reduced amphotericin toxicity in an albumin vehicle. J Drug Target 1993 0.75